Cargando…
Mesua beccariana (Clusiaceae), A Source of Potential Anti-cancer Lead Compounds in Drug Discovery
An investigation on biologically active secondary metabolites from the stem bark of Mesua beccariana was carried out. A new cyclodione, mesuadione (1), along with several known constituents which are beccamarin (2), 2,5-dihydroxy-1,3,4-trimethoxy anthraquinone (3), 4-methoxy-1,3,5-trihydroxyanthraqu...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6268802/ https://www.ncbi.nlm.nih.gov/pubmed/22964497 http://dx.doi.org/10.3390/molecules170910791 |
_version_ | 1783376370459475968 |
---|---|
author | Teh, Soek Sin Cheng Lian Ee, Gwendoline Mah, Siau Hui Lim, Yang Mooi Rahmani, Mawardi |
author_facet | Teh, Soek Sin Cheng Lian Ee, Gwendoline Mah, Siau Hui Lim, Yang Mooi Rahmani, Mawardi |
author_sort | Teh, Soek Sin |
collection | PubMed |
description | An investigation on biologically active secondary metabolites from the stem bark of Mesua beccariana was carried out. A new cyclodione, mesuadione (1), along with several known constituents which are beccamarin (2), 2,5-dihydroxy-1,3,4-trimethoxy anthraquinone (3), 4-methoxy-1,3,5-trihydroxyanthraquinone (4), betulinic acid (5) and stigmasterol (6) were obtained from this ongoing research. Structures of these compounds were elucidated by extensive spectroscopic methods, including 1D and 2D-NMR, GC-MS, IR and UV techniques. Preliminary tests of the in vitro cytotoxic activities of all the isolated metabolites against a panel of human cancer cell lines Raji (lymphoma), SNU-1 (gastric carcinoma), K562 (erythroleukemia cells), LS-174T (colorectal adenocarcinoma), HeLa (cervical cells), SK-MEL-28 (malignant melanoma cells), NCI-H23 (lung adenocarcinoma), IMR-32 (neuroblastoma) and Hep-G2 (hepatocellular liver carcinoma) were carried out using an MTT assay. Mesuadione (1), beccamarin (2), betulinic acid (5) and stigmasterol (6) displayed strong inhibition of Raji cell proliferation, while the proliferation rate of SK-MEL-28 and HeLa were strongly inhibited by stigmasterol (6) and beccamarin (2), indicating these secondary metabolites could be anti-cancer lead compounds in drug discovery. |
format | Online Article Text |
id | pubmed-6268802 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62688022018-12-12 Mesua beccariana (Clusiaceae), A Source of Potential Anti-cancer Lead Compounds in Drug Discovery Teh, Soek Sin Cheng Lian Ee, Gwendoline Mah, Siau Hui Lim, Yang Mooi Rahmani, Mawardi Molecules Article An investigation on biologically active secondary metabolites from the stem bark of Mesua beccariana was carried out. A new cyclodione, mesuadione (1), along with several known constituents which are beccamarin (2), 2,5-dihydroxy-1,3,4-trimethoxy anthraquinone (3), 4-methoxy-1,3,5-trihydroxyanthraquinone (4), betulinic acid (5) and stigmasterol (6) were obtained from this ongoing research. Structures of these compounds were elucidated by extensive spectroscopic methods, including 1D and 2D-NMR, GC-MS, IR and UV techniques. Preliminary tests of the in vitro cytotoxic activities of all the isolated metabolites against a panel of human cancer cell lines Raji (lymphoma), SNU-1 (gastric carcinoma), K562 (erythroleukemia cells), LS-174T (colorectal adenocarcinoma), HeLa (cervical cells), SK-MEL-28 (malignant melanoma cells), NCI-H23 (lung adenocarcinoma), IMR-32 (neuroblastoma) and Hep-G2 (hepatocellular liver carcinoma) were carried out using an MTT assay. Mesuadione (1), beccamarin (2), betulinic acid (5) and stigmasterol (6) displayed strong inhibition of Raji cell proliferation, while the proliferation rate of SK-MEL-28 and HeLa were strongly inhibited by stigmasterol (6) and beccamarin (2), indicating these secondary metabolites could be anti-cancer lead compounds in drug discovery. MDPI 2012-09-10 /pmc/articles/PMC6268802/ /pubmed/22964497 http://dx.doi.org/10.3390/molecules170910791 Text en © 2012 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Article Teh, Soek Sin Cheng Lian Ee, Gwendoline Mah, Siau Hui Lim, Yang Mooi Rahmani, Mawardi Mesua beccariana (Clusiaceae), A Source of Potential Anti-cancer Lead Compounds in Drug Discovery |
title | Mesua beccariana (Clusiaceae), A Source of Potential Anti-cancer Lead Compounds in Drug Discovery |
title_full | Mesua beccariana (Clusiaceae), A Source of Potential Anti-cancer Lead Compounds in Drug Discovery |
title_fullStr | Mesua beccariana (Clusiaceae), A Source of Potential Anti-cancer Lead Compounds in Drug Discovery |
title_full_unstemmed | Mesua beccariana (Clusiaceae), A Source of Potential Anti-cancer Lead Compounds in Drug Discovery |
title_short | Mesua beccariana (Clusiaceae), A Source of Potential Anti-cancer Lead Compounds in Drug Discovery |
title_sort | mesua beccariana (clusiaceae), a source of potential anti-cancer lead compounds in drug discovery |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6268802/ https://www.ncbi.nlm.nih.gov/pubmed/22964497 http://dx.doi.org/10.3390/molecules170910791 |
work_keys_str_mv | AT tehsoeksin mesuabeccarianaclusiaceaeasourceofpotentialanticancerleadcompoundsindrugdiscovery AT chenglianeegwendoline mesuabeccarianaclusiaceaeasourceofpotentialanticancerleadcompoundsindrugdiscovery AT mahsiauhui mesuabeccarianaclusiaceaeasourceofpotentialanticancerleadcompoundsindrugdiscovery AT limyangmooi mesuabeccarianaclusiaceaeasourceofpotentialanticancerleadcompoundsindrugdiscovery AT rahmanimawardi mesuabeccarianaclusiaceaeasourceofpotentialanticancerleadcompoundsindrugdiscovery |